Rituximab: modes of action, remaining dispute and future perspective.

Rituximab: modes of action, remaining dispute and future perspective.

Item
http://www.wikidata.org/entity/Q38294619
Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphomaStructure, development, preclinical and clinical efficacy of blinatumomab in acute lymphoblastic leukemia.The preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma.Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia.TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma.Vaccinations in children on immunosuppressive medications for renal disease.Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions.Successful therapy with rituximab in three patients with probable neurosarcoidosis
P2860

Rituximab: modes of action, remaining dispute and future perspective.

Item
http://www.wikidata.org/entity/Q38294619
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Rituximab: modes of action, remaining dispute and future perspective.
@en
type
label
Rituximab: modes of action, remaining dispute and future perspective.
@en
prefLabel
Rituximab: modes of action, remaining dispute and future perspective.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Rituximab: modes of action, remaining dispute and future perspective
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698